South Korea Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

South Korean diabetes drugs and devices market is segmented by drugs (insulin, oral anti-diabetic drugs, non-insulin injectable drugs, and combination drugs) and devices (management devices such as insulin pumps, insulin pens, syringes, cartridges, and jet injectors, and monitoring devices including self-monitoring blood and continuous glucose monitoring). The report offers the value (in USD) and volume (in unit) for the above segments.

South Korea Diabetes Drugs and Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

South Korea Diabetes Drugs and Devices Industry Overview

Manufacturers have always innovated to survive in the industry. Big industries, as an example, Abbott and Medtronic, have made abundant mergers, acquisitions, and partnerships to secure industry dominance while adhering to biological development techniques. The manufacturers of insulin delivery equipment are spending substantial amounts on the R&D of the gadgets. For example, Novo Nordisk partnered with Abbott Diabetes Care, which may also aid in enabling insulin data to be shared between Novo Nordisk-connected insulin pens and digital health trappings well qualified to the FreeStyle Libre portfolio of cosmetics.

South Korea Diabetes Drugs and Devices Market Leaders

  1. Medtronics

  2. Roche

  3. NovoNordisk

  4. Sanofi

  5. Omnipod

  6. *Disclaimer: Major Players sorted in no particular order
South Korea Diabetes Drugs And Devices Market Concentration

South Korea Diabetes Drugs and Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?